Title |
A European inventory of common electronic health record data elements for clinical trial feasibility
|
---|---|
Published in |
Trials, January 2014
|
DOI | 10.1186/1745-6215-15-18 |
Pubmed ID | |
Authors |
Justin Doods, Florence Botteri, Martin Dugas, Fleur Fritz |
Abstract |
Clinical studies are a necessity for new medications and therapies. Many studies, however, struggle to meet their recruitment numbers in time or have problems in meeting them at all. With increasing numbers of electronic health records (EHRs) in hospitals, huge databanks emerge that could be utilized to support research. The Innovative Medicine Initiative (IMI) funded project 'Electronic Health Records for Clinical Research' (EHR4CR) created a standardized and homogenous inventory of data elements to support research by utilizing EHRs. Our aim was to develop a Data Inventory that contains elements required for site feasibility analysis. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 5 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
United States | 1 | 1% |
Unknown | 90 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 17 | 18% |
Student > Ph. D. Student | 14 | 15% |
Student > Master | 12 | 13% |
Student > Bachelor | 10 | 11% |
Student > Doctoral Student | 6 | 7% |
Other | 20 | 22% |
Unknown | 13 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 24% |
Computer Science | 20 | 22% |
Nursing and Health Professions | 8 | 9% |
Social Sciences | 3 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Other | 16 | 17% |
Unknown | 20 | 22% |